Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...

Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the Neuro-Oncology Translational Research ...

During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...

A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.

Trump has frozen all travel and communications at the Department of Health and Human Services, including the CDC and the ...

One of those meetings concerned cancer research ... and reports from health agencies, including the NIH, the Centers for Disease Control and Prevention and the Food and Drug Administration ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

The US Centers for Disease ... are really scared at NIH and in the academic and scientific community,” Dr. Ned Sharpless, who served as director of the National Cancer Institute from 2017 ...

In his testimony this week, Kennedy claimed that infectious diseases receive far more federal funding than chronic diseases.

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...